ADMP
NASDAQAdamis Pharmaceuticals Corporation
SectorHealth CareIndustryBiotechnology: Pharmaceutical Preparations
Latest news
25 items- SECAdamis Pharmaceuticals Corporation filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing8-K - DMK PHARMACEUTICALS Corp (0000887247) (Filer)
- 13D/GSEC Form SC 13G/A filed by Adamis Pharmaceuticals Corporation (Amendment)SC 13G/A - DMK PHARMACEUTICALS Corp (0000887247) (Subject)
- SECAdamis Pharmaceuticals Corporation filed SEC Form 8-K: Bankruptcy or Receivership, Regulation FD Disclosure, Other Events, Financial Statements and Exhibits8-K - DMK PHARMACEUTICALS Corp (0000887247) (Filer)
- SECAdamis Pharmaceuticals Corporation filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders8-K - DMK PHARMACEUTICALS Corp (0000887247) (Filer)
- SECSEC Form DEFA14A filed by Adamis Pharmaceuticals CorporationDEFA14A - DMK PHARMACEUTICALS Corp (0000887247) (Filer)
- SECAdamis Pharmaceuticals Corporation filed SEC Form 8-K: Material Modification to Rights of Security Holders, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits8-K - DMK PHARMACEUTICALS Corp (0000887247) (Filer)
- SECSEC Form DEFA14A filed by Adamis Pharmaceuticals CorporationDEFA14A - DMK PHARMACEUTICALS Corp (0000887247) (Filer)
- SECAdamis Pharmaceuticals Corporation filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders, Other Events8-K - DMK PHARMACEUTICALS Corp (0000887247) (Filer)
- SECAdamis Pharmaceuticals Corporation filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits8-K - DMK PHARMACEUTICALS Corp (0000887247) (Filer)
- SECAdamis Pharmaceuticals Corporation filed SEC Form 8-K: Results of Operations and Financial Condition8-K - DMK PHARMACEUTICALS Corp (0000887247) (Filer)
- SECSEC Form DEFA14A filed by Adamis Pharmaceuticals CorporationDEFA14A - DMK PHARMACEUTICALS Corp (0000887247) (Filer)
- SECAdamis Pharmaceuticals Corporation filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders, Other Events8-K - DMK PHARMACEUTICALS Corp (0000887247) (Filer)
- SECAdamis Pharmaceuticals Corporation filed SEC Form 8-K: Termination of a Material Definitive Agreement, Other Events, Financial Statements and Exhibits8-K - DMK PHARMACEUTICALS Corp (0000887247) (Filer)
- SECSEC Form DEFA14A filed by Adamis Pharmaceuticals CorporationDEFA14A - DMK PHARMACEUTICALS Corp (0000887247) (Filer)
- SECSEC Form DEFA14A filed by Adamis Pharmaceuticals CorporationDEFA14A - DMK PHARMACEUTICALS Corp (0000887247) (Filer)
- SECAdamis Pharmaceuticals Corporation filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders, Other Events8-K - DMK PHARMACEUTICALS Corp (0000887247) (Filer)
- SECSEC Form DEFA14A filed by Adamis Pharmaceuticals CorporationDEFA14A - DMK PHARMACEUTICALS Corp (0000887247) (Filer)
- SECSEC Form 10-Q filed by Adamis Pharmaceuticals Corporation10-Q - DMK PHARMACEUTICALS Corp (0000887247) (Filer)
- SECAdamis Pharmaceuticals Corporation filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits8-K - DMK PHARMACEUTICALS Corp (0000887247) (Filer)
- INSIDERSEC Form 4 filed by Dorbin John W. Jr.4 - DMK PHARMACEUTICALS Corp (0000887247) (Issuer)
- INSIDERSEC Form 3 filed by new insider Dorbin John W. Jr.3 - DMK PHARMACEUTICALS Corp (0000887247) (Issuer)
- INSIDERSEC Form 4 filed by Cohen Seth4 - DMK PHARMACEUTICALS Corp (0000887247) (Issuer)
- INSIDERSEC Form 3 filed by new insider Cohen Seth3 - DMK PHARMACEUTICALS Corp (0000887247) (Issuer)
- SECAdamis Pharmaceuticals Corporation filed SEC Form 8-K: Entry into a Material Definitive Agreement, Leadership Update, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Financial Statements and Exhibits8-K - DMK PHARMACEUTICALS Corp (0000887247) (Filer)
- SECAdamis Pharmaceuticals Corporation filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Financial Statements and Exhibits8-K - DMK PHARMACEUTICALS Corp (0000887247) (Filer)
ADMP FAQ
5 questionsWhat does Adamis Pharmaceuticals Corporation do?
Adamis Pharmaceuticals Corporation, a specialty biopharmaceutical company, develops and commercializes products in the therapeutic areas of allergy and respiratory disease in the United States. The company's product candidates comprise Symjepi Injection pre-filled syringe (PFS) for use in the emergency treatment of acute allergic reactions, including anaphylaxis; dry powder inhaler products consisting of fluticasone for the treatment of asthma; beclomethasone, a metered dose inhaler product for the asthma; and naloxone injection product candidates for the treatment of opioid overdose. It also...Where does ADMP stock trade?
Adamis Pharmaceuticals Corporation (ADMP) is listed on NASDAQ.What sector and industry is ADMP in?
Adamis Pharmaceuticals Corporation operates in the Health Care sector, Biotechnology: Pharmaceutical Preparations industry.What companies are similar to ADMP?
Notable peers in the same industry include LLY (Eli Lilly and Company), AZN (AstraZeneca PLC), JNJ (Johnson & Johnson), ABBV (AbbVie Inc.), MRK (Merck & Company Inc.). Compare ADMP side-by-side with any of them on Quantisnow.How can I track ADMP on Quantisnow?
Quantisnow aggregates Adamis Pharmaceuticals Corporation's SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow ADMP to receive live email and push alerts on every new disclosure.